
Torpedo Therapeutics
Torpedo Therapeutics is a YC Winter 2022 (W22) company. Based in Boston, MA, USA. Team of 5.
About Torpedo Therapeutics
Summary
Torpedo Therapeutics builds implantable deep brain stimulation devices that both sense and stimulate neural activity with higher spatial precision than current commercial electrodes. The devices target patients with Parkinson's disease, essential tremor, dystonia, and drug-resistant epilepsy, replacing today's open-loop DBS systems that stimulate continuously, lack real-time neural feedback, and require repeated clinic visits to reprogram. The closed-loop design adjusts stimulation based on live neural signals, reducing off-target activation and battery drain from the implanted pulse generator.
From the Y Combinator listing
High-precision, closed-loop neuromodulation devices
We are building high-precision implantable neuromodulation devices that can sense and stimulate neural activity in the brain with the goal of transforming the efficacy and adoption of deep brain stimulation (DBS), an existing FDA-approved therapy used to treat Parkinson’s, essential tremor and epilepsy.
Facts
- Healthcare / Healthcare -> Medical Devices
- Boston, MA, USA
- 5
- Active
- Early
Founders (1)
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works